An interventional study of Madany Closure and Standard closure in Cholecystolithiasis, sponsored by ClinAmygate. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-21.
Sponsored by ClinAmygate · Not applicable, Interventional, and Treatment
this study aims to evaluate the effectiveness of the use of a basic laparoscopic instrument (Only needle holder) with a new technique for port site closure
88 studies on the registry are indexed under Cholecystolithiasis; 17 are open to participants now.
This study's planned enrollment of 90 is close to the median of 100 across 59 interventional studies indexed under Cholecystolithiasis.
Browse Cholecystolithiasis studies →ClinAmygate is the lead sponsor of 18 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
the novel port site closure technique is to be done for this group
Procedure: Madany Closure
external closure of the port site
Procedure: Standard closure
Madany Closure is a new technique for the porte site closure
Standard closure technique of the port site from ecternal
closure time
closure time in seconds
Time frame: 1 day
rate of closure failure
rate failure to close the port site
Time frame: 1 day
incidence of port site infection
incidence of infection of the port site
Time frame: 1 month
incidence of port site hernia
incidence of hernia at the port site
Time frame: 6 weeks
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ClinAmygate